Update on Boehringer Ingelheim’s Access to Healthcare Program in Kenya

Update on Boehringer Ingelheim’s access to healthcare program in Kenya

Since its launch in 2022, the Access to Healthcare program, a partnership between Boehringer Ingelheim and mPharma, has expanded its reach to more than 150,000 people in Kenya. Recently, the initiative enrolled over 10,000 new patients into long-term care management for hypertension and type 2 diabetes. This expansion occurs as Kenya faces a rising burden […] The post Update on Boehringer Ingelheim’s access to healthcare program in Kenya appeare…

Kenya Access Healthcare Program Reaches 150,000 Patients

Kenya Access Healthcare Program supports hypertension and diabetes patients through… The post Kenya Access Healthcare Program Reaches 150,000 Patients appeared first on Femme Hub.